Oncology Biosimilars Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • ID: 4538137
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 4

FEATURED COMPANIES

  • Amgen
  • Baxter
  • Biocon
  • Cipla
  • Dr Reddy's Laboratories
  • F Hoffmann-La Roche
  • MORE
The report on global oncology biosimilars market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global oncology biosimilars market to grow with a CAGR of 32.4% over the forecast period of 2018-2024. The study on oncology biosimilars market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The report on oncology biosimilars market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global oncology biosimilars market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global oncology biosimilars market over the period of 2016 to 2024. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Websites and publications by research agencies
5. Databases such as WTO, OECD, World Bank, and among others.

Segment Covered

The global oncology biosimilars market is segmented on the basis of application and end-user.

Global Oncology Biosimilars Market by Application
  • Cancer Treatment Drugs
  • Supportive Care Drugs
Global Oncology Biosimilars Market by End-User
  • Hospitals
  • Retail Pharmacies
Company Profiles
  • Sandoz
  • Amgen
  • Biocon
  • Hospira
  • F Hoffmann-La Roche
  • Cipla
  • Dr Reddy's Laboratories
  • Pfizer
  • Baxter
  • Sanofi
How this report delivers?

1. Comprehensive analysis of global as well as regional markets of oncology biosimilars market.

2. Complete coverage of all the segments in oncology biosimilars market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in global oncology biosimilars market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen
  • Baxter
  • Biocon
  • Cipla
  • Dr Reddy's Laboratories
  • F Hoffmann-La Roche
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary

3. Global Oncology Biosimilars Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Oncology Biosimilars Market

4. Global Oncology Biosimilars Market by Application
4.1. Cancer Treatment Drugs
4.2. Supportive Care Drugs

5. Global Oncology Biosimilars Market by End-User
5.1. Hospitals
5.2. Retail Pharmacies

6. Global Oncology Biosimilars Market by Region 2018-2024
6.1. North America
6.1.1. North America Oncology Biosimilars Market by Application
6.1.2. North America Oncology Biosimilars Market by End-user
6.1.3. North America Oncology Biosimilars Market by Country
6.2. Europe
6.2.1. Europe Oncology Biosimilars Market by Application
6.2.2. Europe Oncology Biosimilars Market by End-user
6.2.3. Europe Oncology Biosimilars Market by Country
6.3. Asia-Pacific
6.3.1. Asia-Pacific Oncology Biosimilars Market by Application
6.3.2. Asia-Pacific Oncology Biosimilars Market by End-user
6.3.3. Asia-Pacific Oncology Biosimilars Market by Country
6.4. RoW
6.4.1. RoW Oncology Biosimilars Market by Application
6.4.2. RoW Oncology Biosimilars Market by End-user
6.4.3. RoW Oncology Biosimilars Market by Sub-region

7. Company Covered
7.1. Sandoz
7.2. Amgen
7.3. Biocon
7.4. Hospira
7.5. F Hoffmann-la Roche
7.6. Cipla
7.7. Dr Reddy's Laboratories
7.8. Pfizer
7.9. Baxter
7.10. Sanofi
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Sandoz
  • Amgen
  • Biocon
  • Hospira
  • F Hoffmann-La Roche
  • Cipla
  • Dr Reddy's Laboratories
  • Pfizer
  • Baxter
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll